General pharmacological properties of 4,5-diphenyl-2-bis-(2-hydroxyethyl)-aminoxazol (ditazol).
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology* / Q000633:toxicity; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D002746:Chlorpromazine / Q000494:pharmacology; D004983:Ethanolamines / Q000494:pharmacology / Q000633:toxicity; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects; D006168:Guinea Pigs; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D007928:Lethal Dose 50; D008297:Male; D008620:Meprobamate / Q000494:pharmacology; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects; D010080:Oxazoles / Q000494:pharmacology* / Q000633:toxicity; D010437:Peptic Ulcer / Q000139:chemically induced; D010653:Phenylbutazone / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012110:Reserpine; D012640:Seizures / Q000139:chemically induced; D012890:Sleep / Q000187:drug effects
D000893:Anti-Inflammatory Agents; D004983:Ethanolamines; D010080:Oxazoles; D001285:Atropine; D012110:Reserpine; D008620:Meprobamate; D000661:Amphetamine; D010653:Phenylbutazone; D002746:Chlorpromazine; D007213:Indomethacin